Patents by Inventor Alexander Ibraghimov

Alexander Ibraghimov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating lung fibrosis using ST2 polypeptide
    Patent number: 8865645
    Abstract: Methods and compositions for treating fibrosis are disclosed.
    Type: Grant
    Filed: May 23, 2007
    Date of Patent: October 21, 2014
    Assignee: Biogen Idec MA Inc.
    Inventors: Aldo Amatucci, Tatiana Novobrantseva, Alexander Ibraghimov, Alan Gill
  • Dual Variable Domain Immunoglobulins and Uses Thereof
    Publication number: 20110044980
    Abstract: The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease.
    Type: Application
    Filed: July 29, 2010
    Publication date: February 24, 2011
    Applicant: ABBOTT LABORATORIES
    Inventors: Tariq Ghayur, Junjian Liu, Alexander Ibraghimov
  • METHODS OF TREATING FIBROSIS
    Publication number: 20090304699
    Abstract: Methods and compositions for treating fibrosis are disclosed.
    Type: Application
    Filed: May 23, 2007
    Publication date: December 10, 2009
    Applicant: Biogen Idec MA Inc.
    Inventors: Aldo Amatucci, Tatiana Novobrantseva, Alexander Ibraghimov, Alan Gill
  • Methods for treating fibrotic conditions
    Publication number: 20070009518
    Abstract: The present invention is directed to methods for treating fibrosis conditions, such as liver, kidney and lung fibrosis, as well as fibrosis conditions of other tissues of the body. The methods of the invention comprise administering to a patient in need of such treatment a therapeutically effective amount of a B-cell antagonist. Exemplary B-cell antagonists that can be used in the practice of the methods of the invention include antibodies against B-cell surface antigens (e.g., antibodies against CD20), and BAFF antagonists.
    Type: Application
    Filed: May 18, 2006
    Publication date: January 11, 2007
    Applicant: Biogen Idec Inc.
    Inventors: Tatiana Novobrantseva, Shelia Violette, Victor Kotelianski, Alexander Ibraghimov